Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY.

Literature DB >> 14114447

PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY.

C J O'CONNELL, D T KARZON, A L BARRON, M E PLAUT, V M ALI.

Abstract

Keywords: ANTIBODIES; BLOOD PROTEIN ELECTROPHORESIS; BLOOD TRANSFUSION; GAMMA GLOBULIN; GERIATRICS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNE SERUMS; IMMUNITY; LEUKOCYTES; SMALLPOX VACCINE; VACCINIA

Mesh：

Substances：

Year: 1964 PMID： 14114447 DOI： 10.7326/0003-4819-60-2-282

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

31 in total

1. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.

Authors: Rama Rao Amara; Pragati Nigam; Sunita Sharma; Jinyan Liu; Vanda Bostik
Journal: J Virol Date: 2004-04 Impact factor: 5.103

2. Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Authors: Pavlo Gilchuk; Charles T Spencer; Stephanie B Conant; Timothy Hill; Jennifer J Gray; Xinnan Niu; Mu Zheng; John J Erickson; Kelli L Boyd; K Jill McAfee; Carla Oseroff; Sine R Hadrup; Jack R Bennink; William Hildebrand; Kathryn M Edwards; James E Crowe; John V Williams; Søren Buus; Alessandro Sette; Ton N M Schumacher; Andrew J Link; Sebastian Joyce
Journal: J Clin Invest Date: 2013-04-01 Impact factor: 14.808

PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY.

1. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.

2. Discovering naturally processed antigenic determinants that confer protective T cell immunity.

3. Transfer factor: a potential agent for immunotherapy of cancer.

4. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.

Review 5. Interactions of T-and B-lymphocytes and macrophages in recovery from virus infections.

6. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

7. Vaccinia gangrenosa and 1-methylisatin 3-thiosemicarbazone (methisazone).

8. Consequences of smallpox vaccination in leprosy patients.

9. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.

10. Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.